Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 3

Research Article

Safety and Efficacy of the C-117 Formula for Vulnerable Carotid Artery Plaques (Spchim): A Randomized Double-Blind Controlled Pilot Study

Table 3

Plaque characteristics of the two groups.

C-117 formula group (n=59) Placebo group (n=59) Z/TP

Bilateral IMT (mm)

Before treatment1.88 ± 0.441.89 ± 0.41
After treatment1.78 ± 0.351.77 ± 0.33-0.0050.996

Crouse score (mm)

Before treatment4.77 ± 3.063.96 ± 2.60
After treatment3.96 ± 2.603.80 ± 2.91-1.2330.217

Plaque area (mm2)

Before treatment56.07 ± 71.1538.13 ± 29.86
After treatment53.92 ± 55.5838.48 ± 46.60-1.4160.157

Number of vulnerable plaques (n)

Before treatment2.12 ± 1.221.80 ± 0.92
After treatment2.19 ± 1.271.93 ± 1.11-0.9600.337

Number of stable plaques (n)

Before treatment0.33 ± 0.540.25 ± 0.60
After treatment0.31 ± 0.560.24 ± 0.50-0.6730.501

Total number of plaques (n)

Before treatment2.46 ± 1.302.05 ± 1.11
After treatment2.49 ± 1.362.17 ± 1.25-1.2950.195

M, mean ± standard deviation. P is the P value of the FAS dataset;
P<0.05 vs. before treatment.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.